Two more people in New Hampshire have been diagnosed with fungal meningitis related to a national outbreak bringing the number affected in the state to eight. That as the FDA has confirmed that the steroid produced at The New England Compounding Center in Mass is behind the national outbreak.
16 states have reported 257 cases of fungal meningitis to date, including 20 deaths. The victims in the outbreak had all received steroid shots made by the Massachusetts specialty pharmacy, mostly to treat back pain. In New Hampshire, the medication believed to be related to the outbreak was distributed to Pain Care LLC locations in Somersworth, Merrimack and Newington, but the FDA has now expanded their contamination concerns to any type of injectable medication from that Mass pharmacy.
The state Department of Health and Human Services released a list of health care providers who have received products from the New England Compounding Center, and joining the Pain Care locations are Access Sports Medicine in Exeter, Exeter Hospital, Northeast Surgical Care in Newington, Portsmouth Regional Hospital, and Wentworth Douglas Hospital. State Officials say they don't know how many more people might be infected.